CCL3 and breast cancer: Blocking both CD47 and TAG-72 with CAR-T cells was associated with increased levels of macrophage-inflammatory protein (MIP)-1α and MIP-1β chemotactic factors in breast cancers, indicating functionality of the CD47 receptor in this model.